These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7025500)

  • 21. Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study.
    Cesarone MR; Belcaro G; Ippolito E; Pellegrini L; Ledda A; Luzzi R; Ricci A; Dugall M; Bavera P; Hosoi M; Stuard S; Corsi M
    Panminerva Med; 2010 Jun; 52(2 Suppl 1):43-8. PubMed ID: 20657534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness and safety of hydroxyethyl-rutosides in the local treatment of symptoms of venous insufficiency during air travel].
    Gouny AM; Horovitz D; Gouny P; Sauvage E; Nussaume O
    J Mal Vasc; 1999 Jun; 24(3):214-20. PubMed ID: 10467532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open-label, randomised multicentre study comparing the efficacy and safety of CYCLO 3 FORT versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency.
    Beltramino R; Penenory A; Buceta AM
    Int Angiol; 1999 Dec; 18(4):337-42. PubMed ID: 10811525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements.
    Belcaro G; Rulo A; Candiani C
    Vasa; 1989; 18(2):146-51. PubMed ID: 2662674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open-label, randomized multicenter study comparing the efficacy and safety of Cyclo 3 Fort versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency.
    Beltramino R; Penenory A; Buceta AM
    Angiology; 2000 Jul; 51(7):535-44. PubMed ID: 10917578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of large doses of a flavonoid O-(betahydroxyethyl)-rutoside on some aspects of venous circulation].
    Forconi S; Guerrini M
    Clin Ter; 1977 Feb; 80(3):229-55. PubMed ID: 852233
    [No Abstract]   [Full Text] [Related]  

  • 27. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.
    Unkauf M; Rehn D; Klinger J; de la Motte S; Grossmann K
    Arzneimittelforschung; 1996 May; 46(5):478-82. PubMed ID: 8737630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency.
    Rehn D; Unkauf M; Klein P; Jost V; Lücker PW
    Arzneimittelforschung; 1996 May; 46(5):483-7. PubMed ID: 8737631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, cross-over trial of O-(beta-hydroxyethyl) rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
    Faga A
    Br J Plast Surg; 1988 Jul; 41(4):444-5. PubMed ID: 3395777
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of acute symptoms of hemorrhoid disease with high-dose oral O-(beta-hydroxyethyl)-rutosides].
    Annoni F; Boccasanta P; Chiurazzi D; Mozzi E; Oberhauser V
    Minerva Med; 1986 Sep; 77(37):1663-8. PubMed ID: 3531924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Venalot depot in episiotomy. A prospective, consecutive, double-blind study].
    Pedersen KO; Kristensen OK; Gram-Hansen J
    Ugeskr Laeger; 1982 Jan; 144(2):92-3. PubMed ID: 7043841
    [No Abstract]   [Full Text] [Related]  

  • 32. [Local treatment of leg disorders and chronic venous insufficiency. Double blind study of 55 patients].
    Widmer LK; Raps E; Glaus L
    Schweiz Rundsch Med Prax; 1972 Oct; 61(42):1300-4. PubMed ID: 4563622
    [No Abstract]   [Full Text] [Related]  

  • 33. Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency.
    Poynard T; Valterio C
    Vasa; 1994; 23(3):244-50. PubMed ID: 7975870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. O-(beta-hydroxyethyl)-rutosides (Paroven; Venoruton): new studies, improved safety, and novel cardiovascular applications.
    Cesarone MR; Belcaro G; Grossi MG
    Angiology; 2008; 59 Suppl 1():5S-6S. PubMed ID: 18287161
    [No Abstract]   [Full Text] [Related]  

  • 35. [Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
    ZFA (Stuttgart); 1981 Sep; 57(26):1758-60. PubMed ID: 7303836
    [No Abstract]   [Full Text] [Related]  

  • 36. Rutoside and the X-ray induced damage in jejunal mucosa of mouse.
    Rao KR; Fritz-Niggli H
    Strahlentherapie; 1984 Oct; 160(10):624-6. PubMed ID: 6388050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of troxerutin on the flow properties of blood under defined conditions of circulation. A double-blind study of patients with diabetic retinopathy and arteriosclerotic retinopathy].
    Gallasch G; Dörfer C; Schmitt T; Stage A
    Klin Monbl Augenheilkd; 1985 Jul; 187(1):30-5. PubMed ID: 3906246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon.
    Frick RW
    Angiology; 2000 Mar; 51(3):197-205. PubMed ID: 10744007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Benzopyrone in the therapy of postreconstructive edema. A clinical double-blind study].
    Becker HM; Niedermaier G; Orend KH
    Fortschr Med; 1985 Jun; 103(21):593-6. PubMed ID: 4018687
    [No Abstract]   [Full Text] [Related]  

  • 40. A double blind three center clinical trial on the short-term efficacy of 0-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome.
    de Jongste AB; Jonker JJ; Huisman MV; ten Cate JW; Azar AJ
    Thromb Haemost; 1989 Nov; 62(3):826-9. PubMed ID: 2688186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.